Biomimetic cultivation of atrial tissue slices as novel platform for in-vitro atrial arrhythmia studies

Living myocardial slices (LMS) are beating sections of intact human myocardium that maintain 3D microarchitecture and multicellularity, thereby overcoming most limitations of conventional myocardial cell cultures. We introduce a novel method to produce LMS from human atria and apply pacing modalities to bridge the gap between in-vitro and in-vivo atrial arrhythmia studies. Human atrial biopsies from 15 patients undergoing cardiac surgery were dissected to tissue blocks of - 1 cm(2) and cut to 300 mu m thin LMS with a precision-cutting vibratome. LMS were placed in a biomimetic cultivation chamber, filled with standard cell culture medium, under diastolic preload (1 mN) and continuous electrical stimulation (1000 ms cycle length (CL)), resulting in 68 beating LMS. Atrial LMS refractory period was determined at 192 +/- 26 ms. Fixed rate pacing with a CL of 333 ms was applied as atrial tachyarrhythmia (AT) model. This novel state-of-the-art platform for AT research can be used to investigate arrhythmia mechanisms and test novel therapies.

Automated summary

We introduced a novel method to produce living myocardial slices (LMS) from human atria, which can maintain the 3D microarchitecture and multicellularity of intact human myocardium. These LMS can overcome the limitations of conventional myocardial cell cultures and bridge the gap between in-vitro and in-vivo atrial arrhythmia studies. This state-of-the-art platform can be used to investigate arrhythmia mechanisms and test novel therapies.